Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional charges
Summary
Sun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported by strong growth in its domestic formulations business and emerging markets.
Description from Times of India.
Who is covering this
-
Sun Pharma's profit falls on Organon deal charge; specialty drug sales remain strong - Reuters
Sun Pharma's profit falls on Organon deal charge; specialty drug sales remain strong Reuters Sun Pharma Q2 profit plunges 36% on exceptional charges despite revenue growth The Hindu Sun Pharma Q2 Results: PAT falls 36% to Rs 1,989 crore, misses estimates; revenue meets mark...
-
Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional charges
Sun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported by strong growth in its domestic formulations business and emerging markets.